Education
About Us
Working with TipRanks
Follow Us
Nascent Pharma Holdings (NASC)
OTHER OTC:NASC
| Dec 24 | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 0.00 | $ 2.16M | $ 6.69M | $ 4.60M | $ 1.71M |
| Gross Profit | $ -742.32K | $ 358.70K | $ 2.61M | $ 2.99M | $ 1.43M |
| Operating Income | $ -4.76M | $ -7.49M | $ -14.17M | $ -10.27M | $ -7.54M |
| EBITDA | $ -7.65M | $ -5.82M | $ -12.59M | $ -9.52M | $ -7.16M |
| Net Income | $ -10.20M | $ -9.74M | $ -14.92M | $ -12.17M | $ -8.88M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 5.96K | $ 34.01K | $ 73.19K | $ 449.00K | $ 457.80K |
| Total Assets | $ 299.54K | $ 10.13M | $ 15.56M | $ 16.47M | $ 3.91M |
| Total Debt | $ 8.30M | $ 9.18M | $ 9.34M | $ 7.28M | $ 2.08M |
| Net Debt | $ 8.30M | $ 9.15M | $ 9.26M | $ 6.84M | $ 1.62M |
| Total Liabilities | $ 13.02M | $ 11.13M | $ 12.86M | $ 10.86M | $ 2.44M |
| Stockholders' Equity | $ -12.72M | $ -1.00M | $ 2.70M | $ 5.62M | $ 1.48M |
| Cash Flow | |||||
| Free Cash Flow | $ -221.63K | $ -1.32M | $ -3.95M | $ -8.04M | $ -2.00M |
| Operating Cash Flow | $ -221.63K | $ -1.30M | $ -3.95M | $ -7.32M | $ -1.95M |
| Investing Cash Flow | $ 231.32K | $ -84.63K | $ 0.00 | $ -860.79K | $ -25.25K |
| Financing Cash Flow | $ -27.82K | $ 1.35M | $ 3.57M | $ 8.17M | $ 2.38M |
Nascent Pharma Holdings Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.